Skip to main navigation Skip to search Skip to main content

Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)

  • Rui Xiong
  • , Leike Zhang
  • , Shiliang Li
  • , Yuan Sun
  • , Minyi Ding
  • , Yong Wang
  • , Yongliang Zhao
  • , Yan Wu
  • , Weijuan Shang
  • , Xiaming Jiang
  • , Jiwei Shan
  • , Zihao Shen
  • , Yi Tong
  • , Liuxin Xu
  • , Yu Chen
  • , Yingle Liu
  • , Gang Zou
  • , Dimitri Lavillete
  • , Zhenjiang Zhao
  • , Rui Wang
  • Lili Zhu, Gengfu Xiao, Ke Lan, Honglin Li*, Ke Xu*
*Corresponding author for this work
  • East China University of Science and Technology
  • CAS - Wuhan Institute of Virology
  • Wuhan University
  • CAS - Institut Pasteur of Shanghai

Research output: Contribution to journalComment/debate

Abstract

In the original publication there are few errors in Figure 1.

Original languageEnglish
Pages (from-to)76-80
Number of pages5
JournalProtein and Cell
Volume12
Issue number1
DOIs
StatePublished - Jan 2021
Externally publishedYes

Fingerprint

Dive into the research topics of 'Correction to: Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2 (Protein & Cell, (2020), 11, 10, (723-739), 10.1007/s13238-020-00768-w)'. Together they form a unique fingerprint.

Cite this